GlassScriptPhysician profile
Barbara B Carpenter
NPI 1316999774
$7,880.22
in general payments reported to CMS, 2019-2025
25 companies · $1,463 in 2025
The $1,463 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $866 · 2022: $348 · 2023: $1,823 · 2024: $3,380 · 2025: $1,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,721 · Travel and Lodging: $1,873 · Education: $71.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,720.77 |
| Travel and Lodging | $1,873.45 |
| Education | $71.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,490.20 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $635.93 | 2021-2024 | Fasenra, Farxiga, Tezspire |
| Glaxosmithkline, LLC. | $406.70 | 2021-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $364.95 | 2021-2022 | |
| Harmony Biosciences LLC | $269.78 | 2022-2023 | Wakix |
| Idorsia Pharmaceuticals US INC | $262.40 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $249.67 | 2023-2025 | Sunosi, Auvelity |
| Regeneron Healthcare Solutions, INC. | $242.68 | 2025 | Dupixent |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $197.46 | 2023-2024 | |
| Angiodynamics, INC. | $158.36 | 2023 | Auryon Laser System 100-120 Vac |
| Jazz Pharmaceuticals INC. | $148.33 | 2023 | |
| Ucb, INC. | $136.77 | 2021 | |
| Insmed, INC. | $136.58 | 2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.71 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $119.70 | 2024 | Lumryz |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $114.83 | 2025 | |
| Abbvie INC. | $113.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $108.69 | 2021 | |
| Exact Sciences Corporation | $105.30 | 2024 | Cologuard Collection Kit |
| Shionogi INC | $105.24 | 2022-2025 | Fetroja |
| Verona Pharma, INC. | $102.82 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $94.50 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $89.73 | 2021 | |
| Sanofi-Aventis U.S. LLC | $59.80 | 2025 | |
| Merck Sharp & Dohme LLC | $36.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.